Director/PDMR Share Dealing

RNS Number : 7553W
Inspecs Group PLC
24 December 2021
 

24 December 2021

Inspecs Group Plc

("Inspecs" the "Company" or "Group")

 

Director/PDMR Share Dealing

 

On 23 December 2021, the following options to acquire Ordinary Shares of 1 pence each in the capital of the Company ("Ordinary Shares") were granted under the Inspecs Long Term Incentive Plan 2020 ("LTIP") to Robin Totterman and Chris Kay, the Chief Executive Officer and Chief Financial Officer respectively, of the Group. Each option entitled the optionholder to acquire 50,000 Ordinary Shares at an exercise price of 370 pence per Ordinary Share. The options vest on the 23 December 2024, being the third anniversary of grant, subject to the optionholder's continued employment with the Group.

 

1.  Details of the person discharging managerial responsibilities/person closely associated

 

a)  Name

Christopher Kay

2.  Reason for the notification

 

a)  Position/status

Chief Financial Officer

b)  Initial notification / Amendment

Initial notification

3.  Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)  Name

Inspecs Group plc

b)  LEI

2138008Z4S4DHR6NE933

4.  Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)  Description of the financial instrument, type of instrument

Ordinary Shares of 1 pence

b)  Identification code

GB00BK6JPP03

c)  Nature of the transaction

Grant of options over 50,000 ordinary shares with an exercise price of 370 pence per share under the Inspecs Long Term Incentive Plan

d)  Price(s) and volume(s)

 

Price(s)

Volume(s)

 

370 pence

50,000

e)  Aggregated information:

i. Aggregated volume

ii. price

N/A

f)  Date of the transaction

23 December 2021

g)  Place of the transaction

Outside a trading venue

 

 

1.  Details of the person discharging managerial responsibilities/person closely associated

 

a)  Name

Robin Totterman

2.  Reason for the notification

 

a)  Position/status

Chief Executive Officer

b)  Initial notification / Amendment

Initial notification

3.  Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)  Name

Inspecs Group plc

b)  LEI

2138008Z4S4DHR6NE933

4.  Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)  Description of the financial instrument, type of instrument

Ordinary Shares of 1 pence

b)  Identification code

GB00BK6JPP03

c)  Nature of the transaction

Grant of options over 50,000 ordinary shares with an exercise price of 370 pence per share under the Inspecs Long Term Incentive Plan

d)  Price(s) and volume(s)

 

Price(s)

Volume(s)

 

370 pence

50,000

e)  Aggregated information:

i. Aggregated volume

ii. price

N/A

f)  Date of the transaction

23 December 2021

g)  Place of the transaction

Outside a trading venue

 

 

For further information please contact:

 

Inspecs Group plc

Robin Totterman (CEO)

Chris Kay (CFO)

 

via FTI Consulting

Tel: +44 (0) 20 3727 1000

Peel Hunt (Nominated Adviser and Broker)

Adrian Trimmings

Andrew Clark

Will Bell

Tel: +44 (0) 20 7418 8900

 

FTI Consulting (Financial PR)

Alex Beagley

Alice Newlyn

Tel: +44 (0) 20 3727 1000

 

 

About Inspecs Group plc

 

Inspecs is a Bath-based designer, manufacturer and distributor of eyewear frames and optically advanced spectacle lenses. The Group produces a broad range of frames and lenses, covering optical, sunglasses and safety, which are either "Branded" (either under licence or under the Group's own proprietary brands), or "OEM" (including private label on behalf of retail customers and un-branded).

 

In December 2020, Inspecs acquired Eschenbach, a leading, global, eyewear supplier headquartered in Nuremberg, Germany, which includes the American company Tura. The acquisition extended the Group's presence internationally in key global markets. This followed the acquisition of lens maker Norville in July 2020, whereby Inspecs combined two heritage brands in British optical, Savile Row frame maker, and Norville lens maker, further enhancing its vertically integrated business model. As one of only a few companies that can offer this one-stop-shop solution to global retail chains, Inspecs is well positioned to continue to take market share in the globally expanding eyewear market.

 

Inspecs customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 70,000 points of sale.

 

Inspecs has operations across the globe: with offices in the UK, Portugal, Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, the UK and Italy. With the acquisition of Eschenbach, the Group's international reach further extends across Europe and the American markets.

 

The Group's growth strategy going forward is to: (i) continue to grow organically; (ii) undertake further acquisitions (and drive value through leveraging the Group's internal capabilities); and (iii) extend the Group's manufacturing capacity.

 

More information is available at: www.INSPECS.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFLTFVLSFIL
UK 100

Latest directors dealings